In a filing, Astera Labs Inc revealed its Director MAR 2011 CHILDRENS TRUST U/A D acquired Company’s shares for reported $26.79 million on Dec 01 ’25. In the deal valued at $157.57 per share,170,000 shares were bought.
Then, CASA ALAMEDA 2007, LLC bought 33,000 shares, generating $5,199,810 in total proceeds.
Before that, ALBA 2003 LIVING TRUST bought 150,000 shares. Astera Labs Inc shares valued at $23,635,500 were divested by the Director at a price of $157.57 per share.
A number of analysts have revised their coverage, including BNP Paribas Exane’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. Northland Capital also remained covering ALAB and has increased its forecast on November 17, 2025 with a “an Outperform” recommendation from previously “Market perform” rating. TD Cowen maintained its rating on November 05, 2025. It rated ALAB as “a Hold”.
Price Performance Review of ALAB
On Tuesday, Astera Labs Inc [NASDAQ:ALAB] saw its stock fall -13.47% to $142.94. Over the last five days, the stock has lost -3.26%. Astera Labs Inc shares have risen nearly 43.51% since the year began. Nevertheless, the stocks have risen 7.92% over the past one year. While a 52-week high of $262.90 was reached on 09/18/25, a 52-week low of $47.12 was recorded on 04/04/25.
Levels Of Support And Resistance For ALAB Stock
The 24-hour chart illustrates a support level at 129.46, which if violated will result in even more drops to 115.97. On the upside, there is a resistance level at 169.48. A further resistance level may holdings at 196.01.
How much short interest is there in Astera Labs Inc?
A steep rise in short interest was recorded in Astera Labs Inc stocks on 2025-11-14, growing by 1.39 million shares to a total of 10.65 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 9.26 million shares. There was a rise of 13.01%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 05, 2025 when Stifel resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $200.
